YDL185C-A Antibody

What is YDL185C-A Antibody and what experimental applications is it validated for?

YDL185C-A Antibody (CSB-PA314384XA01SVG) specifically recognizes the protein encoded by the YDL185C-A gene in Saccharomyces cerevisiae strain ATCC 204508/S288c, identified by UniProt number P0C5M4 . Based on standard antibody validation practices, this antibody can typically be employed in multiple experimental applications including Western blotting, immunoprecipitation, immunohistochemistry, immunofluorescence, and potentially ELISA or flow cytometry depending on specific validation .

The antibody is available in two size formats (2ml/0.1ml) and is designed for research applications requiring specific detection of the yeast target protein . When designing experiments, researchers should consider that antibody performance varies across applications, making preliminary validation essential.

How does the YDL185C-A Antibody compare to other yeast-targeting antibodies in research applications?

When selecting between different yeast antibodies, researchers should consider:

• Target protein expression levels and localization in their specific yeast strain

• Required assay sensitivity for detection of low-abundance proteins

• Potential cross-reactivity with other yeast proteins

• Compatibility with experimental conditions (fixation methods, buffer compositions)

Unlike therapeutic antibodies such as YM101 (which targets human PD-L1 and TGF-β) , research antibodies for yeast proteins require different optimization considerations due to the thick cell wall and distinct cellular components of yeast.

What are the optimal protocols for sample preparation when using YDL185C-A Antibody in Western blotting?

For optimal detection of the YDL185C-A target in Western blotting, implement this methodological approach:

• Cell Lysis Protocol:

  • Mechanical disruption: Vortex yeast cells with glass beads in lysis buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, 5mM EDTA, protease inhibitors)

  • Alternative: Enzymatic cell wall digestion with zymolyase followed by gentle detergent lysis

  • Centrifuge lysate at 12,000g for 10 minutes at 4°C to remove cell debris

• Protein Denaturation:

  • Mix samples with Laemmli buffer containing SDS and β-mercaptoethanol

  • Heat at 95°C for 5 minutes (consider lower temperatures for membrane proteins)

• Gel Electrophoresis Parameters:

  • Select gel percentage based on target protein size

  • Load consistent protein amounts (20-50μg) across samples

  • Include molecular weight markers and positive control

This preparation method is derived from standard protocols for yeast protein analysis, similar to approaches used in antibody validation studies .

How should researchers optimize conditions for immunoprecipitation with YDL185C-A Antibody?

Immunoprecipitation with YDL185C-A Antibody requires careful optimization similar to processes described for other research antibodies :

• Pre-Clearing Step:

  • Incubate cell lysate with protein A/G beads without antibody for 1 hour at 4°C

  • Remove beads by centrifugation to reduce non-specific binding

• Antibody Binding:

  • Add 2-5μg of YDL185C-A Antibody to pre-cleared lysate

  • Incubate with gentle rotation for 2-4 hours or overnight at 4°C

  • Add 30-50μl protein A/G beads and incubate for 1-2 hours

• Washing Conditions:

  • Perform 4-5 washes with decreasing stringency:

    • First wash: High-salt buffer (500mM NaCl)

    • Middle washes: Standard buffer (150mM NaCl)

    • Final wash: Low-salt buffer (50mM NaCl)

• Controls and Validation:

  • Include IgG isotype control to assess non-specific binding

  • Set aside input sample (5-10% of starting material)

  • Consider knockout/knockdown control where available

This approach mirrors methodological considerations implemented in antibody design and validation protocols referenced in computational antibody development research .

What fixation and permeabilization methods are recommended for immunofluorescence with YDL185C-A Antibody?

Optimizing fixation and permeabilization is critical for successful immunofluorescence with yeast cells. The following table outlines recommended approaches:

For permeabilization after aldehyde fixation, use 0.1% Triton X-100 for 5-10 minutes or 0.5% saponin depending on the subcellular location of the target protein. This methodology draws on principles applied in antibody validation studies that assess binding under various structural conditions .

How can researchers validate the specificity of YDL185C-A Antibody for critical experiments?

Rigorous validation of YDL185C-A Antibody specificity should follow a comprehensive approach:

• Genetic Controls:

  • Compare signal between wild-type yeast and YDL185C-A deletion strains

  • Use CRISPR/Cas9-mediated epitope tagging to confirm antibody recognition

• Peptide Competition:

  • Pre-incubate antibody with excess target peptide (when available)

  • Compare signal with and without competition to identify specific binding

• Multiple Antibody Approach:

  • Compare results using antibodies targeting different epitopes of the same protein

  • Correlation between detection methods suggests specificity

• Orthogonal Validation:

  • Correlate protein detection with mRNA expression data

  • Consider mass spectrometry validation of immunoprecipitated material

• Computational Prediction:

  • Apply computational antibody design principles to predict potential cross-reactivity

  • Use RosettaAntibody-like approaches to model antibody-antigen interactions

This validation strategy incorporates computational antibody design protocols similar to those used in the IsAb methodology, which addresses challenges in antibody specificity prediction .

What approaches should be used to quantify immunofluorescence data from YDL185C-A Antibody experiments?

Quantitative analysis of immunofluorescence data requires methodical approaches:

• Image Acquisition Parameters:

  • Use identical exposure settings across all samples

  • Capture multiple z-stacks to ensure complete signal detection

  • Include positive and negative controls in each imaging session

• Signal Quantification:

  • Define regions of interest (ROIs) consistently across samples

  • Measure mean fluorescence intensity and integrated density

  • Subtract local background for each measurement

  • Calculate signal-to-noise ratio for comparative analysis

• Colocalization Analysis:

  • When performing double-labeling experiments, calculate Pearson's or Mander's coefficients

  • Use appropriate thresholding to avoid artifacts

• Statistical Analysis:

  • Analyze sufficient cells (>30) and biological replicates (n≥3)

  • Apply appropriate statistical tests based on data distribution

  • Report variance and effect sizes alongside p-values

This quantitative approach is aligned with methodologies used in advanced antibody research that require precise measurement of binding characteristics, similar to those implemented in computational antibody design pipelines .

How can researchers troubleshoot non-specific binding issues with YDL185C-A Antibody?

Non-specific binding with YDL185C-A Antibody can be addressed using a systematic approach:

• Blocking Optimization:

  • Test different blocking agents (BSA, casein, commercial blockers)

  • Increase blocking time (2 hours or overnight at 4°C)

  • Add 0.1-0.5% Tween-20 to reduce hydrophobic interactions

• Antibody Dilution Series:

  • Perform a titration series (e.g., 1:500, 1:1000, 1:2000)

  • Select the highest dilution that maintains specific signal

  • Consider longer incubation with more dilute antibody

• Buffer Modifications:

  • Add 5% normal serum from secondary antibody species

  • Increase salt concentration (up to 500mM NaCl) to reduce ionic interactions

  • Add 0.1% SDS to reduce hydrophobic binding

• Alternative Detection Methods:

  • Try different secondary antibodies or detection systems

  • Consider signal amplification methods for weak but specific signals

These troubleshooting approaches reflect methodologies used in antibody validation and optimization protocols referenced in computational antibody design research .

What controls are essential for interpreting YDL185C-A Antibody experimental results?

Proper experimental controls are critical for accurate interpretation of results:

• Positive Controls:

  • Wild-type yeast strain known to express the target protein

  • Recombinant YDL185C-A protein (if available)

  • Yeast strain with tagged version of the target protein

• Negative Controls:

  • YDL185C-A deletion strain (null mutant)

  • Secondary antibody-only control (omit primary antibody)

  • Isotype control antibody (irrelevant antibody of same isotype)

• Technical Controls:

  • Loading controls for Western blots (e.g., PGK1, GAPDH)

  • Dilution series to ensure detection in linear range

  • Multiple biological replicates to assess variability

• Validation Controls:

  • Peptide competition assay to confirm specificity

  • Alternative detection method (mass spectrometry, qPCR)

Implementation of these controls adheres to methodological principles described in computational antibody design protocols, which emphasize the importance of accurately determining binding specificity .

How can machine learning approaches improve YDL185C-A Antibody binding prediction and experimental design?

Recent advances in computational antibody research offer opportunities to enhance YDL185C-A Antibody experiments:

• Binding Prediction:

  • Active learning algorithms can predict antibody-antigen binding with reduced experimental data requirements

  • Library-on-library approaches can identify optimal binding conditions by analyzing many-to-many relationships between antibodies and antigens

• Epitope Mapping:

  • Computational methods like RosettaAntibody can predict potential epitopes by modeling antibody-antigen interactions

  • These predictions can guide experimental design by identifying optimal buffer conditions and potential cross-reactivity

• Experimental Efficiency:

  • Active learning strategies have been shown to reduce the number of required experiments by up to 35%

  • This approach can accelerate research timelines when characterizing new antibodies

• Affinity Maturation:

  • Computational antibody affinity maturation protocols can design improved versions of existing antibodies with better affinity and stability

  • These approaches could potentially enhance YDL185C-A Antibody performance in challenging applications

The application of these computational approaches represents the cutting edge of antibody research methodology, allowing researchers to make more informed decisions when designing experiments with YDL185C-A Antibody .

How does YDL185C-A Antibody performance compare with other yeast protein antibodies in similar experimental contexts?

When comparing performance characteristics of yeast protein antibodies:

• Specificity Comparison:

  • YDL185C-A Antibody should be evaluated alongside other yeast antibodies like YER090C-A (P0C5M8) and YEL050W-A (P0C5M7)

  • Cross-reactivity profiles may differ based on sequence homology between target proteins

• Application Versatility:

  • Some yeast antibodies may perform better in certain applications (Western blot vs. immunofluorescence)

  • Systematic comparison across applications can identify optimal antibody for each technique

• Sensitivity Analysis:

  • Limit of detection for each antibody should be determined using purified protein standards

  • Signal-to-noise ratio comparison provides objective performance metrics

• Reproducibility Assessment:

  • Lot-to-lot variation may differ between antibodies

  • Consistent performance across experiments is a key selection criterion

This comparative approach draws on methodologies used in therapeutic antibody development, where multiple candidates are systematically evaluated before selection .

What emerging techniques could enhance research applications of YDL185C-A Antibody?

Innovative techniques may expand the utility of YDL185C-A Antibody in research:

• Proximity Labeling:

  • Conjugating YDL185C-A Antibody to enzymes like BioID or APEX2

  • Enables identification of protein interaction networks in yeast

• Super-Resolution Microscopy:

  • Combining YDL185C-A Antibody with techniques like STORM or PALM

  • Provides nanoscale localization of target proteins within yeast cellular structures

• Antibody Engineering:

  • Applying computational design principles like those in IsAb protocol

  • Could improve affinity, specificity, or stability of YDL185C-A Antibody

• Microfluidic Applications:

  • Integration with microfluidic platforms for single-cell analysis

  • Enables high-throughput phenotypic studies in yeast populations

These advanced techniques represent the frontier of antibody research applications, drawing on principles established in therapeutic antibody development where novel conjugation and engineering approaches have dramatically expanded antibody utility .